Literatur
- 1
Cappato R, Calkins H, Chen S A. et al .
Prevalence and causes of fatal outcome
in catheter ablation of atrial fibrillation.
J Am Coll
Cardiol.
2009;
53
1789-1803
- 2
Connolly S, Crijns H, Torp-Pedersen C. et al .
Analysis of stroke in ATHENA.
Circulation.
2009;
120
1174-1180
- 3
Connolly S, Ezekowitz M, Yusuf S. et al .
Dabigatran versus warfarin in patients
with atrial fibrillation.
N Engl J Med.
2009;
361
1139-1151
- 4
Hohnloser S, Crijns H, van Eickels M. et al .
Effect of dronedarone on cardiovascular
events in atrial fibrillation.
N Engl J Med.
2009;
360
668-678
- 5
Lewalter T, Tebbenjohanns J, Wichter T, Antz M, Geller C, Seidl K -H, Gulba D, Röhrig F R,
Willems S.
Kommentar zu „ACC/AHA/ESC
2006 guidelines for the management of patients with atrial fibrillation – executive
summary”.
Kardiologe.
2008;
2
181-205
- 6
Wyse D G. et al .
A comparison of rate control and rhythm
control in patients with atrial fibrillation.
N Engl J
Med.
2002;
347
1825-1833
Prof. Dr. med. T. Lewalter
Chefarzt der Abteilung Innere Medizin, St.
Marienhospital, Rheinisches Herz, Gefäß,
und Arrhythmiezentrum Bonn, Akademisches Lehrkrankenhaus
der Universität Bonn
Robert-Koch-Str. 1
53115
Bonn
Phone: 0228/505-2895
Fax: 0228/505-2102
Email: gudrun.yanc@marien-hospital-bonn.de
